SCHEMBL25528043

SCHEMBL25528043

COC(=O)COc1cc(C)c(Cc2ccc(O)c(-c3cccc(OC)c3)c2)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 9/20 0.48
THRB P10828 9/20 0.48
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
VDR P11473 2/20 0.39
PPARD Q03181 2/20 0.39
ESR1 P03372 1/20 0.39
RXRA P19793 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
ESR2 Q92731 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CLK4 Q9HAZ1 2/20 0.37
PDK2 Q15119 1/20 0.37
PLA2G10 O15496 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528034 0.95 THRB (0.50) THRATHRBPDE4APDE4BPDE4C
SCHEMBL25528053 0.92 THRB (0.49) THRATHRBPDK2ALDH1A1KMT2A
SCHEMBL25528046 0.92 THRB (0.56) THRATHRBPPARDPPARGPLA2G10
SCHEMBL25528605 0.92 THRA (0.49) THRATHRBPPARDPPARGADORA2A
SCHEMBL23003641 0.91 THRB (0.47) THRATHRBPDE4APDE4BPDE4C
SCHEMBL23003720 0.90 THRB (0.48) THRATHRBPDK2
SCHEMBL23003824 0.88 THRA (0.47) THRATHRBPPARDPPARGPPARA
SCHEMBL23003714 0.86 THRA (0.50) THRATHRBPDE4DPDK2
SCHEMBL23003771 0.86 THRA (0.61) THRATHRBPPARDPPARGPPARA
SCHEMBL25528533 0.86 THRA (0.51) THRATHRBADORA2AADORA1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885PDE4A 1540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.